Global Hair Transplant Industry

Hair Transplant Market to 2025

Hair Transplant Market to 2025

The global hair transplant market accounted for US$ 5,272.1 Mn in 2017 and is expected to grow at a CAGR of 23.6% during the forecast period 2018 – 2025, to account for US$ 28,627.6 Mn by 2025.

North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period. North American market is driven by the factors such as government initiatives, investments made by the major companies, conferences held for the awareness regarding hair transplant.

Market Insights

The rise in the Number of Surgical Hair Restoration Procedures

In recent years, there has been a considerable rise in the number of surgical hair restoration procedures. Hair transplant surgery offers benefits such as original hair colour and appearance, and the results are permanent.

The process is completely safe and does not include harmful chemicals that might cause harm to the individual. The above-stated factors are responsible for the increase in the demand for hair transplant procedures worldwide. This gradual increase in the number of hair transplant surgeries is anticipated to increase the demand for transplant in the forecast period.

Increase in the Number of Hair Transplant Procedures among Men

Hair transplant procedures have been opted by men on a large scale in the past few years. Since men are more prone to baldness, they hold maximum share as the users of hair transplant procedures. According to the International Society of Hair Restoration Surgery, the percentage of men undergoing hair transplant surgery increased from 84.7% in 2014 to 85.7% in 2016.

Factors such as rising work pressure, stress, improper eating habits, heredity, and exposure to chemicals among others, cause hair fall and receding hairline. Growing media and celebrity influence, societal pressure, and growing urbanization are some of the factors encouraging individuals to opt for hair transplant procure in order to enhance their physical appearance.


Procedure Insights

The global hair transplant market by procedure was led by the surgical segment. In 2017, the surgical segment held the largest market share of 91.0% of the hair transplant market, by the procedure. The segment is also expected to dominate the market in 2025, as it offers better results as compared to the non-surgical procedure. Also, the procedure can be done on lashes and brows.

Site of Transplant Insights

The hair transplant market by the site of the transplant was segmented scalp transplant, facial transplant, chest transplant, and others. The scalp segment held the largest share of the market, by the site of the transplant. Additionally, the segment is likely to dominate in the forecast period, due to the increasing prevalence of baldness.

Therapy Insights

The hair transplant market by therapy was segmented into platelet-rich plasma, ravage 670 and laser caps. The platelet-rich plasma segment held the largest share of the market, by therapy. The segment is also anticipated to grow at a steady rate during the forecast period, as it is used for the treatment of androgenic alopecia or male pattern baldness, the most common form of baldness observed in males and females.

Strategic Insights

Product launches and approvals were observed as the most adopted strategy in the global hair transplant industry. Few of the recent product launches and approvals made by the players are listed below;

2018: In March 2018, HairMax received ANVISA approval for laser devices. Also, Restoration Robotics Received US FDA 510(k) clearance for implantation function.

2016: In February 2016, Hair restoration leader, capillus launches newest FDA-cleared solution for hair loss: capillus202 mobile laser therapy cap.


By Procedure

  • Surgical Procedure
    • Follicular Unit Strip Surgery (FUSS)
    • Follicular Unit Extraction
    • Others
    • Non-Surgical Procedure

By Site of Transplant

  • Scalp
  • Facial
  • Eyebrow
  • Bread
  • Eyelash
  • Chest
  • Others

By Therapy

  • Platelet Rich Plasma
  • Revage 670 Laser
  • Laser Cap

By Geography

•   North America

  • U.S.
  • Canada
  • Mexico

•   Europe

  • France
  • Germany
  • UK

•   Asia Pacific (APAC)

  • China
  • India
  • Japan

•   Middle East & Africa (MEA)

  • Saudi Arabia
  • South Africa
  • UAE

•   South America (SAM)

  • Brazil

Company Profiles

  • Cole Instruments Inc.,
  • LaserCap Company
  • Apira Science
  • Harris FUE Instruments
  • HairMax Inc.
  • FueInstrument
  • Shaanxi Xingmao Industry Co., Ltd
  • Restoration Robotics, Inc.

Hair Transplant Market to 2025


Recent Posts

Global Anti-dandruff Agent Ingredients Market

Selenium Sulfide Market Forecast to 2027

Selenium Sulfide Market Forecast to 2027


Selenium sulfide belongs to a class of anti-infective agents. It functions by slowing the growth of fungi yeast which usually causes an infection. Selenium sulfide is used to treat hair problems especially dandruff and several scalp infections. Selenium sulfide helps to stop flaking, irritation, itching of the scalp. Selenium sulfide is available in the form of lotion and shampoo.


The key market drivers for the Selenium Sulfide Market Includes, rising demand for selenium sulfide in pharmaceutical industries due to its antifungal properties and applications for personal grooming, hair care products.

Moreover, the use of selenium sulfide in diseases like seborrheic dermatitis and dandruff care is also expected to fuel market growth. Additionally, risen demand for selenium sulfide in the chemical industry is also expected to boost market growth.

However, potential side effects from selenium sulfide are expected to restrain the market growth during the forecast period.


The “Selenium Sulfide Market” is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Selenium Sulfide market with detailed market segmentation by application and end-user. The Selenium Sulfide Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in the Selenium Sulfide Market and offers key trends and opportunities in the market.


The Selenium Sulfide Market is segmented on the basis of application and end-user. On the basis of application, the market is segmented as, an anti-infective agent, disease treatment and others. And on the basis of end-user, the market is segmented as, pharmaceuticals, commercial and others.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the Selenium Sulfide Market based on various segments. It also provides market size and forecast estimates from the year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Selenium Sulfide Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting Selenium Sulfide Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the Selenium Sulfide Market in these regions.


The report covers key developments in the Selenium Sulfide Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved the way for the expansion of the business and customer base of market players.

The market players from Selenium Sulfide Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Selenium Sulfide market in the global market. Below mentioned is the list of few companies engaged in the Selenium Sulfide Market.

The report also includes the profiles of key players in the Selenium Sulfide Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of the last 3 years, key development in the past five years.

Omkar Speciality Chemicals
BOC Sciences
Tractus Company Limited
Macsen Laboratories
Muby Chemicals
Abbott Laboratories
Macsen Drugs

The Insight Partner’s dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Selenium Sulfide Market Forecast to 2027


Recent Posts

Global Hair Transplant Industry

Hair Transplant Market Size

Hair Transplant Market Size study, by Product Type, By Application, and Regional Forecasts 2020-2026

HeyReport estimates that the Hair Transplant market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025 and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025.

In this report, HeyReport discusses the Global & China industrial policies, economic environment, and the impact of covid-19 on the Hair Transplant industry and its cost structure.

Besides, this report covers the basic market dynamics, market size and companies competition data. In addition, the report also conducts basic market research on major product type, market end-use and regional trade.

Market Segment as follows:

Product Type Segmentation Includes
Follicular Unit Transplantation (FUT)
Follicular Unit Extraction (FUE)

Application Segmentation Includes


Companies Includes

Bernstein Medical
Ethics hair instruments
Restoration Robotics

The main contents of the report including:

Section 1:
Product definition, type and application, Global & China market overview;

Section 2:
Global & China Market competition by company;

Section 3:
Global & China sales revenue, volume and price by type;

Section 4:
Global & China sales revenue, volume and price by application;

Section 5:
China export and import;

Section 6:
Company information, business overview, sales data and product specifications;

Section 7:
Industry chain and raw materials;

Section 8:
Industrial policies & economic environment

Section 9:


For any other requirements, please feel free to contact HeyReport for customized contents.

Hair Transplant Market Size study, by Product Type, By Application, and Regional Forecasts 2020-2026


Recent Posts

Global Anti-dandruff Agent Ingredients Market

Dandruff Treatment Market

Global Dandruff Treatment Market Research Report 2021-2025

These dandruff shampoos encourage the healing of scales on your scalp. In the context of the China-US trade war and the COVID-19 epidemic, it will have a big influence on this market. Dandruff Treatment Report by Material, Application, and Geography Global Forecast to 2025 is a professional and comprehensive research report on the worlds major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Dandruff Treatment market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.

The report firstly introduced the Dandruff Treatment basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the worlds main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc.

In the end, the report introduced a new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include:

Arcadia Consumer Healthcare
Vyome Therapeutics

The end users/applications and product categories analysis:

On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-

General Type

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Dandruff Treatment for each application, including-


Global Dandruff Treatment Market Research Report 2021-2025


Recent Posts

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies

Stem Cell and Platelet Rich Plasma Alopecia Therapies

COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size, Status and Forecast 2020-2026t

This report focuses on the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Orange County Hair Restoration Center
Hair Sciences Center of Colorado
Anderson Center for Hair
Evolution Hair Loss Institute
Savola Aesthetic Dermatology Center
Virginia Surgical Center
Hair Transplant Institute of Miami
Colorado Surgical Center & Hair Institute

Market segment by Type, the product can be split into

Platelet Rich Plasma Injections
Stem Cell Therapy
Market segment by Application, split into
Dermatology Clinics

Market segment by Regions/Countries, this report covers

North America
Southeast Asia
Central & South America

The study objectives of this report are:

To analyze global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies status, future forecast, growth opportunity, key market and key players.
To present the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies are as follows:

History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Get the latest Market Research Reports on COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies. Industry analysis & Market Report on COVID-19 Impact on Global Stem

Cell and Platelet Rich Plasma (PRP) Alopecia Therapies is a syndicated market report, published as COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size,

Status and Forecast 2020-2026. It is a complete Research Study and Industry Analysis of COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market, to understand,

Market Demand, Growth, trends analysis and Factor Influencing market.

COVID-19 Impact on Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size, Status and Forecast 2020-2026


Recent Posts

Europe Shampoo Market

Europe Shampoo Market

Europe Shampoo Market – Growth, Trends, and Forecast (2020 – 2025)

The Europe Shampoo market is projected to grow at a CAGR of 4.1% during the forecast period (2020 – 2025).

– Growing awareness about hair care products through social media, magazines, and TV advertisements are encouraging consumers to purchase various hair care products especially anti-dandruff and medical shampoo.

– Rising concerns over hair related issues, growing consumer inclination towards hair maintenance, and newly formulated product launches are projected to remain prominent market trends.

Key Market Trends

Rising Popularity of Herbal Shampoo

Organic and natural products are emerging as significant product segments in the European haircare market. With rising awareness regarding scalp-related issues and hair-fall, consumers are increasingly inclining towards herbal and natural hair care solutions. With evolving consumer needs for shampoo products comprising of natural ingredients, manufacturers are continuously expanding their product portfolio. For example, in 2019,

Loreal launched a “new generation” of professional hair care products that are exclusively used in salons. These shampoos are natural, silicone-free, paraben-free, and sulfate-free formulas with 80-100% naturally-derived ingredients. The product range is formulated with real flower and plant inclusions suspended. Moreover, the consumers are looking for shampoos infused with oils, included blended formulations and pure organics, thus, providing healthy fixes for dry and damaged hair.

Germany Holds a Significant Share in the Market

German people are stifled by the high relative costs of hair treatments and a shortage of time. They are more interested in natural hair-care products. The ongoing wellness and sustainability trends in the region are driving a surging consumer interest in natural hair care products. Younger consumers, in particular, are driving interest in sustainability and eco-friendliness, while consumers across demographics and a large section of the ex-pat population are concerned about potential health risks created by the use of chemicals in products.

Furthermore, the manufacturers are leveraging online platforms optimally, by selling their products through their own websites as well as by listing the products on popular e-retailing websites, in order to improve their brand visibility and reachability of products.​

Competitive Landscape

The shampoo market is highly competitive, with the presence of various international and domestic players. The key players in the market are focusing on leveraging opportunities posed by emerging markets, to expand their product portfolio, thus, catering to consumer’s needs for various hair concerns. Some of the major players in the global shampoo market are, L’Oréal SA, Unilever PLC, The Procter & Gamble Company, Kao Corporation among others.

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format

– 3 months of analyst support

Europe Shampoo Market – Growth, Trends, and Forecast (2020 – 2025)


Recent Posts

Facial Hair Transplantation

Dr Bared Co-Authors Hair Transplant Surgery Textbook

Miami Plastic Surgeon Dr Anthony Bared Co-Authors Hair Transplant Surgery Textbook

Dr Anthony Bared, a highly-respected Miami board-certified plastic surgeon and hair restoration specialist, has been published in the Hair Transplant Surgery and Platelet Rich Plasma textbook by editor Linda N. Nee.

The new handbook is suited for beginners to advanced surgeons in the rapidly-emerging field of hair transplantation.

Editor Linda N. Nee selected experts in facial plastic surgery and dermatology to write chapters in the text. Dr Anthony Bared, MD, wrote Chapter 10, Techniques in Beard and Eyebrow Restoration. The book begins with the basics and leads to advanced surgical tips with cutting-edge information.

Dr Lee, Dr Bared, and the other co-authors offer surgical tips needed by clinicians and surgeons to achieve natural-looking results.

Dr Bared specializes in beard restoration, which is an emerging trend in cosmetic surgery.

Patients visit Dr Bared in Miami, FL, to seek beard transplants for various reasons, including a desire for thicker facial hair due to genetic factors, to reverse laser hair removal, or to conceal facial burns, scarring, or cleft lip repair. Female to male transgender patients may also request information on facial hair restoration for a more masculine appearance.

Dr Bared customizes each transplant to match the patient’s desired shape and density. Men seeking facial hair transplantation typically have a specific idea of how they want their beard to appear, and Dr Bared asks them to be actively involved in the design process. Male patients may require a secondary procedure depending on the size and density of the desired beard.

At his Miami practice, Dr Bared also offers his advanced skills in eyebrow restoration, a popular treatment requested by men and women to perfect the eyebrow’s shape, density, and the hair’s natural direction and angle.

Eyebrow restoration is beneficial to women experiencing thinning eyebrows caused by genetics, over-plucking, or ageing. Some forms of alopecia, such as alopecia totalis (complete absence of the eyebrow), may affect eyebrow restoration candidacy. Men often lose the lateral aspect of the eyebrow due to ageing and desire thicker eyebrows for cosmetic reasons.

Men and women can bring photos of eyebrows and use eyeliner to fill in the brow for Dr Bared to see the look they want to achieve. The patient is actively involved in the design of their eyebrows.

Facial hair transplant specialist Dr Bared is double board-certified by the American Board of Plastic and Reconstructive Surgery and the American Board of Otolaryngology.

Advanced follicular unit extraction (FUE) techniques allow patients to avoid linear scars if they wear short haircuts. Dr Bared gives his patients flexibility and fantastic results using the FUE technique. He has performed over 1000 facial hair restoration procedures at his Miami practice.

If you are interested in a beard or eyebrow restoration request a consultation with Dr Anthony Bared, MD, FACS in Miami, Florida, or visit Facial Plastic Surgery Miami.

Miami Plastic Surgeon Dr Anthony Bared Co-Authors Hair Transplant Surgery Textbook


Recent Posts

Hair Regrowth in Phase 3 Alopecia Areata

Hair Regrowth in Phase 3 Alopecia Areata

Baricitinib is First JAK-Inhibitor to Demonstrate Hair Regrowth in Phase 3 Alopecia Areata (AA) Trial

Eli Lilly and Company announced today top-line results from BRAVE-AA2, a Phase 3 study evaluating the efficacy and safety of once-daily baricitinib 2-mg and 4-mg in adults with severe alopecia areata (AA).

Both doses of baricitinib met the primary efficacy endpoint at Week 36, demonstrating a statistically significant improvement in scalp hair regrowth compared to those randomized to placebo. AA is an autoimmune disease that causes patchy hair loss on the scalp, face and sometimes on other areas of the body that can progress.

Baricitinib has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for the treatment of AA. This classification aims to expedite the development and review of drugs that are intended to treat a serious condition when preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over already available therapies on a clinically significant endpoint(s). There are currently no FDA-approved treatments for AA.

“These positive results are very promising and suggest that baricitinib has the potential to address the urgent needs of people living with alopecia areata,” said Brett King, M.D., Ph.D., associate professor of Dermatology at Yale School of Medicine. “This level of high-quality research is needed to advance our understanding and the treatment of this frequently devastating disease.”

This multicenter, randomized, double-blind, placebo-controlled study included 546 adults with a Severity of Alopecia Tool (SALT) score ≥ 50 (i.e., who had ≥50% scalp hair loss) and a current episode of severe AA lasting at least six months but no more than eight years. The study included a diverse patient population from Argentina, Australia, Brazil, China, Israel, Japan, South Korea, Taiwan and the U.S.

Safety outcomes of baricitinib in BRAVE-AA2 were consistent with its established safety profile in patients with rheumatoid arthritis (RA) and atopic dermatitis (AD). No deaths, major adverse cardiovascular events (MACE) or venous thromboembolic events (VTEs) were reported in the study.

BRAVE-AA2 is the first Phase 3 study with positive results in patients with AA. Data from an additional Phase 3 study of baricitinib in AA will be available in the first half of this year. Detailed results from the BRAVE program will be presented at an upcoming medical conference and published in a peer-reviewed journal later this year. AA is the second potential treatment indication in dermatology for baricitinib after AD.

“For patients who suffer from alopecia areata, it is not a cosmetic condition, it is a devastating autoimmune disease that can have significant psychological effects. They lose much more than just hair,” said Lotus Mallbris, M.D., Ph.D., vice president of immunology development at Lilly. “We are looking forward to sharing the totality of data from the overall clinical development program for baricitinib as a potential first-in-disease treatment for alopecia areata.”

“Significant unmet need exists in the treatment of alopecia areata,” said Abby Ellison, research director at the National Alopecia Areata Foundation (NAAF). “We appreciate Lilly’s important work in this area and are excited that these data could bring us closer to a potential new treatment option for patients.”

Baricitinib is an oral JAK inhibitor discovered by Incyte and licensed to Lilly. It is approved and commercially available as OLUMIANT in the U.S. and more than 70 countries as a treatment for adults with moderate to severe active RA and in the European Union and Japan for the treatment of adult patients with moderate to severe AD who are candidates for systemic therapy. Baricitinib is also being investigated in systematic lupus erythematosus (SLE), juvenile idiopathic arthritis (JIA) and COVID-19.

Baricitinib is First JAK-Inhibitor to Demonstrate Hair Regrowth in Phase 3 Alopecia Areata (AA) Trial


Recent Posts

Facial Hair Transplantation

Facial Hair Transplantation

Dr. Anthony Bared Takes Part in Facial Hair Transplantation

Acclaimed Miami plastic surgeon and hair transplant specialist Dr. Anthony Bared recently participated in a study conducted by PubMed, MEDLINE, and Embase databases on the topic of facial hair transplantation for transgender patients.

research was conducted by looking at studies published through April 2020 discussing facial hair transplant in transmasculine patients. The goal of the study, published by Oxford University Press (Aesthetic Surgery Journal 2021,1-10), was to review current literature around the topic of facial hair transplantation to offer best practices and recommendations for surgeons providing this life-changing procedure that is becoming increasingly popular.

By determining common threads in the medical literature, invaluable conclusions were drawn during the study that have the potential to benefit thousands of patients worldwide. The review process began by looking at literature from the databases of PubMed, Embase and MEDLINE. Data was gathered from all relevant studies through April of 2020 and broken down so that valuable meta-analysis could be conducted.

The data exported from these studies include demographics, outcomes, specific techniques, complications, side-effects and patient satisfaction. The results provided many useful conclusions that led Dr. Bared and his colleagues to create recommendations for surgeons serving transmasculine patients.

The study comes in the wake of the increasing demand for facial hair transplantation in transmasculine patients. Transmasculine patients, transgender individuals assigned female at birth but identifying as male, are a growing segment of the population seeking gender reassignment surgery. As such, research seeking to improve aesthetic factors in this group is seeing greater interest. Dr. Anthony Bared is an authority on plastic surgery and has a commitment to serving transgender patients.

Hair transplantation can play a life-changing role in the process of gender reassignment surgeries but tailoring the outcome to transmasculine patients requires greater specialization than most surgeons possess. Dr. Anthony Bared’s clinic has seen an increased influx of transgender patients seeking hair restoration in recent years. Procedures such as eyebrow transplantation, hairline lowering and pubic hair transplants are common for male-to-female patients.

On the other hand, female-to-male patients typically seek hair procedures that focus on beard and body hair. The study conducted by Dr. Bared and his colleagues provides valuable insight into the role that hair transplantation plays in the lives of transmasculine patients and maps out a surgical path to attaining optimal results.

Dr. Anthony Bared’s medical training started with Otolaryngology at the University of Miami. He was later awarded a highly competitive fellowship by the American Academy of Facial Plastic and Reconstructive Surgery. His credentials include being double board-certified by the American Board of Otolaryngology and the American Board of Facial Plastic and Reconstructive Surgery.

Dr. Bared’s office is located in Miami, FL. The doctor is recognized by patients and peers alike for his expertise in surgical and non-surgical procedures and treatments, especially hair transplantation.

Dr. Anthony Bared Takes Part in Facial Hair Transplantation


Recent Posts

Global Alopecia Treatment Market

Speaker discusses use of JAK inhibitors in alopecia

Speaker discusses use of JAK inhibitors in alopecia

A speaker at South Beach Symposium Medical Dermatology Summit discussed the JAK inhibitors that are currently on the market and their applications in treating alopecia areata.

Antonella Tosti, MD, said that JAK inhibitors “are probably the future of treatment for alopecia areata.”

Of the three main JAK inhibitors used for alopecia areata — ruxolitinib, baricitinib and tofacitinib — tofacitinib “has been most studied,” Tosti said. The standard dose of tofacitinib is 5 mg twice daily.

Patients usually regrow hair about 3 months after beginning treatment, and even though some patients may take longer, they should “persist and continue the treatment,” she said.

About 70% of patients respond to tofacitinib, although it is typically less effective in long-standing alopecia totalis or alopecia universalis. However, the oral formulation is more effective than the topical formulation, Tosti said.

Large clinical trials for ruxolitinib and baricitinib are ongoing, according to Tosti. In the literature cited during the presentation, ruxolitinib doses were 10 mg twice daily and 10 mg every other day. She also said “usually ruxolitinib causes visible regrowth earlier than tofacitinib.”

There is not yet data on long-term side effects, but patients commonly experience upper respiratory infections, headache and weight gain. Given the potential danger of upper respiratory infections during the era of COVID-19, Tosti has advised her patients to discontinue treatment if they develop COVID-19 symptoms. Other side effects, such as severe infection, have been reported among patients taking a JAK inhibitor for another indication.

Tosti said there are several JAK inhibitor compounds in the phase 2 or 3 stage of development.

Speaker discusses use of JAK inhibitors in alopecia


Recent Posts